Live Breaking News & Updates on Mnov

Stay informed with the latest breaking news from Mnov on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mnov and stay connected to the pulse of your community

MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. MediciNova Trading Up 1.6 % MNOV opened at $1.30 on Friday. MediciNova has a twelve month low of $1.26 and a […]

United-states , Zurich , Züsz , Switzerland , Squarepoint-ops , Medicinova-inc , Morgan-stanley , Virtu-financial , Bank-julius-baer-co , Ltd-zurich , Get-free-report

MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report sent to investors on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Performance NASDAQ:MNOV opened at $1.36 on Friday. The stock has a 50-day simple moving average of $1.48 and a 200-day simple moving […]

Montreal , Quebec , Canada , United-states , Citigroup-inc , Nasdaq , Capricorn-fund-managers-ltd , Medicinova-inc , Medicinova-company-profile , Dimensional-fund-advisors , Free-report

MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Price Performance Shares of NASDAQ:MNOV opened at $1.36 on Friday. MediciNova has a 12 month low of $1.29 and a 12 month high […]

United-states , America , Jpmorgan-chase-co , America-corp , Nasdaq , Dimensional-fund-advisors , Renaissance-technologies , Medicinova-inc , Medicinova-company-profile , Free-report , Street-corp

MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report released on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Performance Shares of MNOV stock opened at $1.42 on Friday. The stock has a market cap of $69.41 million, a PE ratio of -7.45 […]

United-states , Zurich , Züsz , Switzerland , Morgan-stanley , Virtu-financial , Ltd-zurich , Medicinova-inc , Squarepoint-ops , Bank-julius-baer-co , Free-report

StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV)

Equities research analysts at StockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a research report issued on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. MediciNova Trading Down 2.4 % NASDAQ:MNOV opened at $1.41 on Thursday. MediciNova has a 12-month low of $1.30 and a 12-month […]

United-states , Zurich , Züsz , Switzerland , Bank-julius-baer-co , Capricorn-fund-managers-ltd , Blackrock-inc , Medicinova-inc , Ltd-zurich , Nasdaq , Citigroup-inc

MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Trading Down 2.6 % Shares of MNOV opened at $1.47 on Wednesday. MediciNova has a 1-year low of $1.30 and a 1-year high […]

United-states , Medicinova-inc , Renaissance-technologies , Dimensional-fund-advisors , Geode-capital-management , Jpmorgan-chase-co , Free-report , Nova-trading-down , Get-free-report , Capital-management , Fund-advisors

MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Down 2.6 % Shares of MNOV stock opened at $1.47 on Wednesday. The stock has a fifty day moving average of $1.61 and a 200 […]

United-states , Medicinova-inc , Renaissance-technologies , Jpmorgan-chase-co , Medicinova-company-profile , Dimensional-fund-advisors , Geode-capital-management , Free-report , Nova-stock-down , Get-free-report , Capital-management

MediciNova (NASDAQ:MNOV) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova Price Performance Shares of NASDAQ:MNOV opened at $1.65 on Friday. The business’s 50 day simple moving average is $1.73 and its 200-day simple […]

Montreal , Quebec , Canada , United-states , Zurich , Züsz , Switzerland , Citigroup-inc , Bank-julius-baer-co , Dimensional-fund-advisors , Nasdaq

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com

StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a research note published on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Performance MNOV opened at $1.46 on Friday. MediciNova has a fifty-two week low of $1.42 and a fifty-two week high of $2.66. The company […]

United-states , Dimensional-fund-advisors , Geode-capital-management , Jpmorgan-chase-co , Renaissance-technologies , Medicinova-inc , Free-report , Get-free-report , Capital-management , Fund-advisors , State-street-corp

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com

StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report released on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. MediciNova Stock Performance NASDAQ:MNOV opened at $1.51 on Friday. The stock has a market capitalization of $74.07 million, a P/E ratio of -7.95 and a beta of […]

United-states , Morgan-stanley , Squarepoint-ops , Nasdaq , Medicinova-inc , Virtu-financial , Capricorn-fund-managers-ltd , Free-report , Get-free-report , Point-capital-management , Medicinova-daily